Aspen Pharmacare Holdings Ltd.’s deal to make Covid-19 vaccines for Johnson & Johnson caps a broader effort by Africa’s biggest drugmaker to adapt to the pandemic, having earlier re-purposed older medicines and deployed anesthetics to battle the virus.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push